These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 25135845)
1. Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Berges R; Höfner K; Gedamke M; Oelke M World J Urol; 2014 Oct; 32(5):1163-70. PubMed ID: 25135845 [TBL] [Abstract][Full Text] [Related]
2. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice. Chen SL; Huang YH; Hung TW; Ou YC Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study. Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of Desmopressin to Treat Nocturnal Polyuria in Elderly Men: Effects on Sleep Quality. Kim SO; Yu HS; Kwon D Urol Int; 2016; 96(4):438-42. PubMed ID: 26836495 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Weiss JP; Herschorn S; Albei CD; van der Meulen EA J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402 [TBL] [Abstract][Full Text] [Related]
6. The impact of adding low-dose oral desmopressin therapy to tamsulosin therapy for treatment of nocturia owing to benign prostatic hyperplasia. Ahmed AF; Maarouf A; Shalaby E; Gabr AH; Shahin A; Ghobish A World J Urol; 2015 May; 33(5):649-57. PubMed ID: 25138579 [TBL] [Abstract][Full Text] [Related]
7. [INITIAL TREATMENT OF NOCTURIA CAUSED BY NOCTURNAL POLYURIA WITH LOW-DOSE DESMOPRESSIN]. Hayashi K; Fuji K; Omizu M; Hiramatsu A; Koizumi S; Matsubara E; Saito K; Yamagishi M; Sasaki H; Fukagai T; Ishikawa K; Ogawa Y Nihon Hinyokika Gakkai Zasshi; 2021; 112(1):18-24. PubMed ID: 35046231 [TBL] [Abstract][Full Text] [Related]
8. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms. Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213 [TBL] [Abstract][Full Text] [Related]
9. Desmopressin for treating nocturia in men. Han J; Jung JH; Bakker CJ; Ebell MH; Dahm P Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012059. PubMed ID: 29055129 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. Sand PK; Dmochowski RR; Reddy J; van der Meulen EA J Urol; 2013 Sep; 190(3):958-64. PubMed ID: 23454404 [TBL] [Abstract][Full Text] [Related]
11. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study. Xue Z; Lin Y; Jiang Y; Wei N; Bi J BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338 [TBL] [Abstract][Full Text] [Related]
12. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. Wang CJ; Lin YN; Huang SW; Chang CH J Urol; 2011 Jan; 185(1):219-23. PubMed ID: 21074790 [TBL] [Abstract][Full Text] [Related]
13. [Nocturia in men with benign prostatic hyperplasia]. Oelke M; Fangmeyer B; Zinke J; Witt JH Aktuelle Urol; 2018 Aug; 49(4):319-327. PubMed ID: 30086589 [TBL] [Abstract][Full Text] [Related]
14. Desmopressin is an effective treatment for mixed nocturia with nocturnal polyuria and decreased nocturnal bladder capacity. Lee HW; Choo MS; Lee JG; Park CH; Paick JS; Lee JZ; Han DH; Park WH; Lee KS J Korean Med Sci; 2010 Dec; 25(12):1792-7. PubMed ID: 21165296 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group development program. Yamaguchi O; Juul KV; Falahati A; Yoshimura T; Imura F; Kitamura M Low Urin Tract Symptoms; 2020 Jan; 12(1):8-19. PubMed ID: 31397969 [TBL] [Abstract][Full Text] [Related]
16. Monocentric single-arm study of desmopressin acetate efficacy on nocturnal polyuria in the elderly. Palmieri B; Iannitti T; Morales-Medina JC; Vadalà M Int J Clin Pract; 2020 Nov; 74(11):e13612. PubMed ID: 32668490 [TBL] [Abstract][Full Text] [Related]
17. Low-dose Desmopressin Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria. Weiss JP; van der Meulen EA; Juul KV Eur Urol Focus; 2020 Sep; 6(5):1006-1012. PubMed ID: 30470646 [TBL] [Abstract][Full Text] [Related]
18. Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature. Taha DE; Aboumarzouk OM; Shokeir AA Arab J Urol; 2018 Dec; 16(4):404-410. PubMed ID: 30534439 [TBL] [Abstract][Full Text] [Related]
20. Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies. Oelke M; Weiss JP; Mamoulakis C; Cox D; Ruff D; Viktrup L World J Urol; 2014 Oct; 32(5):1127-32. PubMed ID: 24504761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]